United Therapeutics Corporation (UTHR) recently gained approval for the commencement of a phase I study in Australia using Pluristem...(read more
We recently reiterated a Neutral recommendation on United Therapeutics (UTHR).
While the company reported strong third-quarter results, United Therapeutics suffered a major...(read more
This Weeks Value Stock Pick - United Therapeutics
Zacks Investment Research reports United Therapeutics Corporation (UTHR) performed above expectations in the first half of 2012 and is positioned...(read more